This report focuses on the global Cancer Screening status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Screening development in United States, Europe and China.
In 2017, the global Cancer Screening market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.
The key players covered in this study
Abbott
Roche
Fujirebio Diagnostics, Inc.
BioMérieux
Beckman Coulter
Clarient
Siemens
DiaSorin
Qiagen
Xeptagen
Orion Genomics.
Hologic, Inc.
Market segment by Type, the product can be split into
Blood Tests
Urine Tests
Medical Imaging
Other
Market segment by Application, split into
Women
Men
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Screening status, future forecast, growth opportunity, key market and key players.
To present the Cancer Screening development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cancer Screening are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.